Gilead’s HIV prevention treatment found 100% effective in late-stage trial
Gilead Sciences Inc.’s stock jumped early Thursday after the company said its experimental injection for HIV prevention was found 100% effective in a late-stage trial.
September has historically been the worst month for U.S. stocks — but not this year
Homeowners looking to leverage lower mortgage rates can ask their lenders for a “rate modification,” financial experts say.
It’s rescued investors in the past from a lost decade
‘There’s this debate between a hard landing, a soft landing or no landing that continues,’ says Lerner at Truist Advisory...
Some analysts warn the pool of potential gold buyers could begin to run dry.
Boeing Co. said that Ted Colbert — its head of defense, space and security — would leave the company on...